U.S. flag

An official website of the United States government

Results: 1 to 20 of 135

Make selection to find tests for any of the checked conditions.[x]
ConditionsSynonyms
Type 2 diabetes mellitus
  • DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST
  • Diabetes mellitus, noninsulin-dependent, late onset
  • KCNJ11-Related Susceptibility to Noninsulin-Dependent Diabetes Mellitus
  • Type II diabetes mellitus
Short-rib thoracic dysplasia 6 with or without polydactyly
  • Majewski Syndrome
  • POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE II
  • Polydactyly with neonatal chondrodystrophy type 2
  • SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA
  • SHORT-RIB THORACIC DYSPLASIA 6 WITH POLYDACTYLY
  • SHORT-RIB THORACIC DYSPLASIA 6 WITHOUT POLYDACTYLY
Retinitis pigmentosa 2
  • Retinitis pigmentosa 2, X linked
Sandhoff disease
  • Beta-hexosaminidase-beta-subunit deficiency
  • GM2 gangliosidosis, type 2
  • GM2-GANGLIOSIDOSIS, TYPE II
  • HEXOSAMINIDASES A AND B DEFICIENCY
  • Hexosaminidase A and B deficiency Disease
  • Sandhoff-Jatzkewitz-Pilz disease
  • Total hexosaminidase deficiency
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2
  • MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6
Schizophrenia
Charcot-Marie-Tooth disease axonal type 2C
  • CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2C
  • Charcot-Marie-Tooth Neuropathy Type 2C
  • Charcot-Marie-Tooth disease type 2C
  • Hereditary motor and sensory neuropathy 2 C
Incontinentia pigmenti syndrome
  • Bloch-Sulzberger syndrome
  • INCONTINENTIA PIGMENTI, TYPE II
  • IP2 (formerly)
  • Incontinentia Pigmenti
  • Incontinentia pigmenti type 2 (formerly)
  • Incontinentia pigmenti, familial male-lethal type
Severe myoclonic epilepsy in infancy
  • DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6A
  • Dravet syndrome
  • Epilepsy, Myoclonic, Infantile, Severe
  • Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)
Cone-rod dystrophy 6
  • Cone dystrophy progressive
  • Retinal cone dystrophy 2
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
  • Mitochondrial DNA depletion syndrome type 6
  • Navajo neurohepatopathy
  • Navajo neuropathy
Langer-Giedion syndrome
  • CHROMOSOME 8q24.1 DELETION SYNDROME
  • Deletion 8q24.1
  • Monosomy 8q24.1
  • TRPS 2
  • Trichorhinophalangeal syndrome type 2
  • Trichorhinophalangeal syndrome type II
Familial infantile myasthenia
  • CHAT-Related Congenital Myasthenic Syndrome
  • Congenital myasthenic syndrome 6
  • Congenital myasthenic syndrome with episodic apnea
  • FIMG2 (formerly)
  • MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC
  • Myasthenic syndrome congenital associated with episodic apnea
  • Myasthenic syndrome, presynaptic, congenital, associated with episodic apnea
Nonpapillary renal cell carcinoma
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2
  • MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2, SOMATIC
Fucosidosis
  • Alpha-l-fucosidase deficiency
  • Lysosomal storage disease caused by defective alpha-L-fucosidase with accumulation of fucose in the tissues
Sialidosis type 2
  • CHERRY RED SPOT--MYOCLONUS SYNDROME
  • Glycoprotein neuraminidase deficiency
  • Lipomucopolysaccharidosis
  • ML I
  • Mucolipidosis I
  • Mucolipidosis type 1
  • NEU 1 deficiency
  • NEU DEFICIENCY
  • Neuraminidase 1 deficiency
  • Neuraminidase deficiency
  • Sialidase deficiency
  • Sialidosis, type II
Diamond-Blackfan anemia 6
  • Aase-Smith syndrome II
  • RPL5-Related Diamond-Blackfan Anemia
Cataract 6 multiple types
  • CATARACT 6, CONGENITAL TOTAL
  • CATARACT 6, POSTERIOR POLAR
  • CATARACT, AGE-RELATED CORTICAL, 2
  • Cataract, posterior polar, 1
Spondyloepimetaphyseal dysplasia, Maroteaux type
  • PSEUDO-MORQUIO SYNDROME, TYPE 2
  • SED, Maroteaux type
  • Spondyloepiphyseal dysplasia Maroteaux type

Results: 1 to 20 of 135

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.